2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma (G-HOPE-001)Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaActive, not recruitingPhase 32026-05-13NCT06238843
JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.Advanced Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingPhase 32026-01-22NCT07284134